Brandon Rockwell is President & Chief Operating Officer at PAI Pharma, a leading U.S.-based manufacturer of liquid and sterile generic pharmaceuticals. In his role, Brandon leads the full P&L and is responsible for the day-to-day operations and long-term growth strategy of the company. His scope includes oversight of Commercial, Operations, R&D, Regulatory Affairs, Quality and Business Development functions.

Brandon brings nearly 20 years of pharmaceutical industry experience across branded, sterile, and generic markets, with a track record of driving portfolio expansion, operational execution, and strategic M&A. Prior to PAI, he served on the Executive Leadership Team at Endo Pharmaceuticals, where he held various roles culminating in his position as Senior Vice President of Business Development & Strategy. He also held senior leadership roles at Par Pharmaceutical, where he oversaw Business Development, Portfolio, and Project Management during a period of significant growth.

Brandon holds an MBA from the New Jersey Institute of Technology and a Bachelor of Science from Grove City College.